Mandate

Vinge advises Flygfältsbyrån in connection with sale to COWI

July 08, 2009

Vinge has advised Flygfältsbyrån AB in connection with the sale of its operations to COWI A/S (through the sale of FB Engineering AB, FB Management AB and AEC Investment AB and subsidiaries).

The target companies’ operations include providing expert engineering services to private and public sector clients within industry, infrastructure, construction and property development as well as CAD/IT. Flygfältsbyrån is one of Sweden’s leading technology groups with its headquarters in Gothenburg and the group employs a total of 760 people. Flygfältsbyrån has been operating in this sector for over 60 years.

The COWI group is a global technology consultancy group specialising in engineering technology, environment, and economics. COWI has been operating in these sectors over 80 years. Following the merger with Flygfätsbyrån, MOWI will have approximately 6000 employees.

Vinge’s team consisted of Olof Jisland, Managing Partner of the Gothenburg office, assisted by Max Glanzelius. Partner Raoul Svensson was responsible for tax law issues and partner Susann Vahlenbreder was responsible for intellectual property law issues.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025